Displaying drugs 2551 - 2575 of 2809 in total
Oxaceprol
Experimental
S-40503
S-40503 is an investigational selective androgen receptor modulator (SARM) developed for the treatment of osteoporosis by the Japanese company Kaken Pharmaceuticals.
Experimental
Guanosine-5'-Monophosphate
Guanosine 5'-monophosphate. A guanine nucleotide containing one phosphate group esterified to the sugar moiety and found widely in nature. [PubChem]
Experimental
RWJ-56423
Experimental
Faropenem medoxomil
Faropenem medoxomil is an ester prodrug derivative of the beta-lactam antibiotic faropenem. The prodrug form of faropenem offers dramatically improved oral bioavailability and leads to higher systemic concentrations of the drug. Faropenem medoxomil is a broad-spectrum antibiotic that is highly resistant to beta-lactamase degradation. It is being developed jointly by...
Investigational
Delanzomib
Delanzomib has been used in trials studying the treatment of Solid Tumors, Multiple Myeloma, and Lymphoma, Non-Hodgkin.
Investigational
Biapenem
Biapenem has been used in trials studying the treatment of Bacterial Infections.
Investigational
Clefamide
Experimental
Ribavirin monophosphate
Experimental
7-methyl-7,8-dihydroguanosine-5'-diphosphate
Experimental
Phosphoaminophosphonic acid guanylate ester
A non-hydrolyzable analog of GTP, in which the oxygen atom bridging the beta to the gamma phosphate is replaced by a nitrogen atom. It binds tightly to G-protein in the presence of Mg2+. The nucleotide is a potent stimulator of adenylate cyclase.
Experimental
Adenosine Phosphonoacetic Acid
Experimental
Adenosine-5'-Pentaphosphate
Experimental
Beta-Hydroxyleucine
Experimental
N-Pyridoxyl-Threonine-5-Monophosphate
Experimental
Aurodox
Aurodox is an antibiotic obtained from a streptomyces variant considered as possibly effective against streptococcus pyogenes infections. It may promote growth in poultry.
Experimental
Aplyronine A
Experimental
Apadenoson
Apadenoson is a selective A2a adenosine receptor agonist designed for use as a pharmacologic stress agent in cardiac perfusion imaging studies. It is developed by Bristol-Myers Squibb and is in phase II of clinical trials.
Investigational
Displaying drugs 2551 - 2575 of 2809 in total